A Novel Inhibitor of Gyrase B Is a Potent Drug Candidate for Treatment of Tuberculosis and Nontuberculosis Mycobacterial Infections
出版年份 2014 全文链接
标题
A Novel Inhibitor of Gyrase B Is a Potent Drug Candidate for Treatment of Tuberculosis and Nontuberculosis Mycobacterial Infections
作者
关键词
-
出版物
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 59, Issue 3, Pages 1455-1465
出版商
American Society for Microbiology
发表日期
2014-12-23
DOI
10.1128/aac.04347-14
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Optimization of Pyrrolamides as Mycobacterial GyrB ATPase Inhibitors: Structure-Activity Relationship andIn VivoEfficacy in a Mouse Model of Tuberculosis
- (2014) Shahul Hameed P et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroActivity of AZD5847 against Geographically Diverse Clinical Isolates of Mycobacterium tuberculosis
- (2014) Jim Werngren et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Gyrase ATPase Domain as an Antitubercular Drug Discovery Platform: Structure-Based Design and Lead Optimization of Nitrothiazolyl Carboxamide Analogues
- (2014) Variam Ullas Jeankumar et al. ChemMedChem
- Second-Generation Antibacterial Benzimidazole Ureas: Discovery of a Preclinical Candidate with Reduced Metabolic Liability
- (2014) Anne-Laure Grillot et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis
- (2014) Robert S. Wallis et al. PLoS One
- Bactericidal Activity and Mechanism of Action of AZD5847, a Novel Oxazolidinone for Treatment of Tuberculosis
- (2013) V. Balasubramanian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Thiazolopyridone ureas as DNA gyrase B inhibitors: Optimization of antitubercular activity and efficacy
- (2013) Ramesh R. Kale et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase B
- (2013) Manoj G. Kale et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fragment-to-Hit-to-Lead Discovery of a Novel Pyridylurea Scaffold of ATP Competitive Dual Targeting Type II Topoisomerase Inhibiting Antibacterial Agents
- (2013) Gregory S. Basarab et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents
- (2013) Leslie W. Tari et al. PLoS One
- Aminopyrazinamides: Novel and Specific GyrB Inhibitors that Kill Replicating and Nonreplicating Mycobacterium tuberculosis
- (2012) Pravin S. Shirude et al. ACS Chemical Biology
- Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: Development of inhibitors with broad spectrum, Gram-negative antibacterial activity
- (2012) Micheal Trzoss et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Short-Course Chemotherapy with TMC207 and Rifapentine in a Murine Model of Latent Tuberculosis Infection
- (2011) Tianyu Zhang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The oxazolidinones: past, present, and future
- (2011) Karen Joy Shaw et al. Annals of the New York Academy of Sciences
- Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis
- (2011) S. Chopra et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fast Standardized Therapeutic-Efficacy Assay for Drug Discovery against Tuberculosis
- (2010) J. Rullas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Short-Course Therapy with Daily Rifapentine in a Murine Model of Latent Tuberculosis Infection
- (2009) Tianyu Zhang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis
- (2009) D. Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Dual-Targeting Benzimidazole Urea Inhibitors of DNA Gyrase and Topoisomerase IV Possessing Potent Antibacterial Activity: Intelligent Design and Evolution through the Judicious Use of Structure-Guided Design and Stucture−Activity Relationships
- (2008) Paul S. Charifson et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More